Clinical Utility of Circulating Tumor Cells
Mark C. Connelly, PhD, from Janssen Research & Development, suggests that circulating tumor cells (CTCs) are an effective independent predictor of progression-free survival and overall survival. CTCs can be used to monitor patients during treatment.
Watch video Clinical Utility of Circulating Tumor Cells online without registration, duration hours minute second in high quality. This video was added by user OncLive 05 December 2014, don't forget to share it with your friends and acquaintances, it has been viewed on our site 373 once and liked it 5 people.